Article Versions Notes

Ospanov M, Sulochana SP, Paris JJ, Rimoldi JM, Ashpole N, Walker L, Ross SA, Shilabin AG, Ibrahim MA. Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor. Molecules. 2022; 27(2):509. https://doi.org/10.3390/molecules27020509

Ospanov, Meirambek, Suresh P. Sulochana, Jason J. Paris, John M. Rimoldi, Nicole Ashpole, Larry Walker, Samir A. Ross, Abbas G. Shilabin, and Mohamed A. Ibrahim. 2022. "Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor" Molecules 27, no. 2: 509. https://doi.org/10.3390/molecules27020509

Ospanov, M., Sulochana, S. P., Paris, J. J., Rimoldi, J. M., Ashpole, N., Walker, L., Ross, S. A., Shilabin, A. G., & Ibrahim, M. A. (2022). Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor. Molecules, 27(2), 509. https://doi.org/10.3390/molecules27020509